Cargando…
Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations
Pancreatic neuroendocrine tumors (PNETs) are known to be the second most common epithelial malignancy of the pancreas. PNETs can be listed among the slowest growing as well as the fastest growing human cancers. The prevalence of PNETs is deceptively low; however, its incidence has significantly incr...
Autores principales: | Mpilla, Gabriel Benyomo, Philip, Philip Agop, El-Rayes, Bassel, Azmi, Asfar Sohail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403797/ https://www.ncbi.nlm.nih.gov/pubmed/32821069 http://dx.doi.org/10.3748/wjg.v26.i28.4036 |
Ejemplares similares
-
PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors
por: Mpilla, Gabriel, et al.
Publicado: (2019) -
Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth
por: Khan, Husain Yar, et al.
Publicado: (2020) -
Management and Outcomes of Hospitalized Patients With Primary Neuroendocrine Tumor and Non-Neuroendocrine Tumor Appendiceal Cancers in the United States
por: Alese, Olatunji B., et al.
Publicado: (2015) -
Connecting the Human Microbiome and Pancreatic Cancer
por: Sexton, Rachel E., et al.
Publicado: (2022) -
Small molecule tyrosine kinase inhibitors in pancreatic cancer
por: Gupta, Sachin, et al.
Publicado: (2008)